Long-term consequences of Kawasaki disease: A 10- to 21-year follow-up study of 594 patients

Circulation

Volumn 94, Issue 6, 1996, Pages 1379-1385

  Kato, Hirohisa ^a   Sugimura, Tetsu ^a   Akagi, Teiji ^a   Sato, Noboru ^a   Hashino, Kanoko ^a   Maeno, Yasuki ^a   Kazue, Takeyo ^a   Eto, Genzyu ^a   Yamakawa, Rumi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

aneurysm; coronary disease; Kawasaki disease; myocardial infarction; valves

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INFANT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REMISSION; VALVULAR HEART DISEASE;

EID: 0029814477     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1379     Document Type: Article

References (27)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy. 1967;16:178-222.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271-276.
3. Kato H, Akagi T, Sugimura T, Sato N, Kazue T, Hashino K, Nishiyori A, Sakaguchi M. Kawasaki disease. Coron Artery Dis. 1995;6:194-206.
4. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892-898.
5. Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev. 1988;9:209-217.
6. Taubert KA, Rowley AH, Shulman ST. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994;13:704-708.
7. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet. 1992;340:1127-1129.
8. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175-179.
9. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinamiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Baba K, Mori C. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055-1058.
10. Akagi T, Kato H, Inoue O, Sato N. Salicylate treatment in Kawasaki disease: high dose or low dose? Eur J Pediatr. 1991;150:642-646.
11. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol. 1982;49:1758-1766.
12. Nakano H, Ueda K, Saito A, Mojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1985;56:846-851.
13. Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr. 1987;111:705-710.
14. Kamiya T. Report of Research Committee of Kawasaki Disease: The Evaluation of Coronary Artery Lesions by Echocardiography and Coronary Angiography. Tokyo, Japan: The Health and Welfare Press; 1983:1-10.
15. Sato N, Kato H. Echocardiographic evaluation in Kawasaki disease. Med Pract. 1990;7:1725-1732.
16. Fukuda T. Myocardial ischemia in Kawasaki disease: evaluation by dipyridamole stress thallium-201 myocardial imaging and exercise stress test. Kurume Med J. 1992;39:245-255.
17. Kato H, Inoue O, Ichinose E, Akagi T, Sato N. Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn. 1991;33:27-35.
18. Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol 1995;25:1420-1424.
19. Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1994;74:822-824.
20. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathologic study. J Pediatr. 1982;100:225-231.
21. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, Takagi J, Akagi T, Maeno Y, Kawano T, Takagishi T, Sasaguri Y. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation. 1994;89:258-265.
22. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992;121:684-688.
23. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy E, Fulton DR, Glode MP, Mason WH, Meissner C, Rowley AH, Shulman ST, Reddy MD, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
24. Tomita S, Chung K, Mas M, Gidding S, Shulman ST. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis. 1992;14:121-126.
25. Nakano H, Nojima K, Saito A, Ueda K, High incidence of aortic regurgitation following Kawasaki disease. J Pediatr. 1985;107:5963.
26. Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to valvulitis. J Am Coll Cardiol. 1986;7:894-897.
27. Akagi T, Kato H, Inoue O, Sato N. Valvular heart disease in Kawasaki syndrome: incidence and natural history. Am Heart J. 1990;120:366-367.